Recent advances in peptide-based therapy for Type 2 diabetes and obesity

Abstract

The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.

Publication DOI: https://doi.org/10.1016/j.peptides.2021.170652
Divisions: College of Health & Life Sciences
Additional Information: © 2021, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Publication ISSN: 1873-5169
Last Modified: 02 Apr 2024 07:25
Date Deposited: 21 Sep 2021 10:43
Full Text Link:
Related URLs: https://linking ... 196978121001601 (Publisher URL)
PURE Output Type: Editorial
Published Date: 2021-11
Published Online Date: 2021-09-20
Accepted Date: 2021-09-01
Authors: Conlon, J. Michael
Flatt, Peter R.
Bailey, Clifford J. (ORCID Profile 0000-0002-6998-6811)

Export / Share Citation


Statistics

Additional statistics for this record